The portfolio was classified as Equity (EC) and U.S. (US). Cash was $106,567.49, while the reported net asset figure after that cash position was $1,493,428,334.19.
Fidelity Covington Trust’s Fidelity MSCI MaterialsindexETF reported $578,673,904.64 ($578.7 million) in netAssetsas of 2026-07-31, with Air Products and Chemicals at 4.205034637796% of the portfolio. Investors can use the disclosed weights and dollar values to identify the fund’s reported materials exposures.Key HighlightsFidelity MSCI Materials Index …
Fidelity Covington Trust reported $1,730,317,975.71 ($1.73 billion) in total net assets for the Fidelity MSCI Communication Services Index ETF as of July 31. Alphabet Inc (NASDAQ: GOOG)’s 02079K305 line carried the largest disclosed portfolio weight at 14.66%, followed by Alphabet Inc’s 02079K107 line at …
AXIA Energia S.A. insider Falconi Campos Vicente reported a transaction involving 2,311 derivative securities at $10.74 per share. The transaction was dated September 22, 2026, and carried code J. AXIA Energia’s reported record places Vicente’s post-transaction position at 9,475 derivative securities.
Batista de Lima Filho Pedro bought 91,000 shares of AXIA Energia S.A. at $10.55 per share across six transactions. The purchases involved an insider of AXIA Energia S.A. with each transaction recorded on 21 September 2026.
Natera, Inc. (NASDAQ: NTRA) director Sheena Jonathan plans to sell 21,064 common shares valued at approximately $8,163,402. The transaction is recorded on a Form 144 dated 09/23/2026. Charles Schwab (NYSE: SCHW) & Co. Inc. is identified in the record in connection with the proposed …
Cardiol Therapeutics Inc. (NASDAQ: CRDL) is a biotechnology company. Tejara Capital Ltd reports ownership of 5.3% of Cardiol Therapeutics, equal to 6,382,551 Class A common shares.
Cardiol Therapeutics Inc. (NASDAQ: CRDL) is a biotechnology company. Tejara Capital Ltd reported ownership of 5.3% of Cardiol Therapeutics, covering 6,382,551 Class A common shares. The position was described as held in the ordinary course without an intent to change or influence control.
Pharvaris Insider Transactions Detail
UBS AG’s preliminary terms put the public issue price at $1,000 per note for trigger callable contingent yield notes tied to the least performing linked asset. The securities are due on or about September 7, 2028, subject to completion of the final offering documents. …